Document Detail

Ischemia/Reperfusion-Induced Renal Failure in Rats as a Model for Evaluating Cell Therapies.
MedLine Citation:
PMID:  23030045     Owner:  NLM     Status:  Publisher    
Chronic renal failure is a devastating disease that leads to a multitude of complications. Cell therapy has emerged as a potential treatment modality for renal failure. However, efficacy testing on systemic renal function has been challenging due to the limited availability of reliable models that are fully characterized. In this study, we investigated the possibility of using renal ischemia/reperfusion (I/R) injury as a viable model for testing cell therapies. We examined functional and pathological changes in rat kidneys that were exposed to different ischemia times. Male Lewis rats were divided into five groups. Renal failure was induced by clamping both renal pedicles for combinations of 60, 75, and 90 min, followed by reperfusion. Age-matched healthy rats served as controls. Blood was collected at regular intervals for serum chemistry, and kidneys were harvested at the same intervals for histomorphological assessment. Serum creatinine levels of the animals with I/R injury increased significantly after 3 days and returned to normal levels at 4 weeks. Histologically, kidney tissue showed progressive glomerular and tubular deterioration with varying degrees of fibrosis. Animals exposed to 75- and 90-min ischemia combination times consistently generated more severe injury than the 60-min ischemia period. However, these groups resulted in a high mortality rate. A model in which one kidney is exposed to a shorter ischemia time (60 or 90 min) resulted in sustained renal damage with a lower mortality rate. This study shows that kidneys exposed to I/R result in renal tissue damage as well as decreased renal function. This model can be used to study both the short-term and longer-term effects of kidney disease by varying the length of the ischemic time. In particular, the use of longer ischemic times (75 and 90 min) could be used to study new therapies for acute renal disease, whereas shorter ischemic times (60 min) could be used to study therapies for chronic renal insufficiency.
Hung-Jen Wang; Adam Varner; Tamer Aboushwareb; Anthony Atala; James J Yoo
Related Documents :
24721605 - Large-for-size liver transplantation: a flowmetry study in pigs.
6186575 - Kidney ageing and renal excretion of amylase.
8504625 - Pharmacokinetics of temocapril and enalapril in patients with various degrees of renal ...
25131035 - Clinical evaluation of hepatic transection on pediatric liver transplantation.
2568815 - Renal excretion and computed tomography enhancement of iotrolan and iopamidol in dogs.
19917375 - Electrolyte free water clearance could be an early sign of renal dysfunction in renal t...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-3
Journal Detail:
Title:  Renal failure     Volume:  -     ISSN:  1525-6049     ISO Abbreviation:  Ren Fail     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8701128     Medline TA:  Ren Fail     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences , Winston-Salem, NC , USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Molecular Dynamics Simulations to Examine Structure, Energetics and Evaporation/Condensation Dynamic...
Next Document:  Bacterial community composition associated with freshwater algae: species specificity versus depende...